Prothena Corp. plc Stock
Prothena Corp. plc Stock
Heavy losses for Prothena Corp. plc today as the stock fell by €0.000 (-3.530%).
With 11 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of 15 € there is a hugely positive potential of 82.93% for Prothena Corp. plc compared to the current price of 8.2 €.
Our community identified positive and negative aspects for Prothena Corp. plc stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Prothena Corp. plc stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Prothena Corp. plc in the next few years
Pros
?
S********** s********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prothena Corp. plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prothena Corp. plc | -3.530% | 11.565% | 8.609% | -41.007% | 0.000% | -83.597% | -54.444% |
| Heron Therapeutics Inc. | -2.290% | -17.606% | -21.563% | -62.646% | -25.224% | -61.789% | -94.320% |
| Evolus Inc | 0.000% | 34.254% | 32.787% | -60.488% | -10.826% | -42.143% | -46.417% |
| Sangamo Therapeutics Inc. | 1.170% | -11.687% | -2.689% | -65.046% | -6.890% | -86.281% | -96.585% |
Comments
Prothena (NASDAQ:PRTA) had its price target raised by analysts at HC Wainwright from $20.00 to $30.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena (NASDAQ:PRTA) was given a new $20.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena (NASDAQ:PRTA) had its price target lowered by analysts at Piper Sandler from $81.00 to $15.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for PRTA provided by MarketBeat